CollPlant
Formerly CollPlant Holdings Ltd
Products and Technologies for Regenerative and Aesthetic Medicine
Startup Mature Health Tech & Life Sciences Est. 2004
🌐 WebsiteLinkedInTwitter
Total Raised
$89.05M
Mature
Last Round
$3.6M
14 rounds
Investors
7
7 public
Team
4
51-200 employees
Confidence
100/100
News
138
articles
About
CollPlant is a regenerative and aesthetic medicine company developing technologies and products for tissue regeneration and organ manufacturing. Its revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, CollPlant is developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
BiologicalsGenesMachinery & Robotics3D Printing & Additive Manufacturing
Target Customer
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business Model
B2B
Tags
orthopedicsregenerative-medicinebiomaterialstissue-regenerationpharmaceuticalstreatmentsmedical-devicesnanotechnology3d-technologydrug-deliverymedical-productsmedical-technologies
Funding & Events
Sep 2019
PIPE $5.5M
Undisclosed Investor(s)
Sep 2017
PIPE $5M
Alpha Capital
Sep 2006
Undisclosed Round $1.5M
Oct 2018
Exit Undisclosed
Oct 2013
Undisclosed Round $2.5M
Undisclosed Investor(s)
Nov 2017
PIPE $7.4M
Meitav Dash
Nov 2012
PIPE $2.8M
Yelin Lapidot Investment House, Meitav Dash
May 2025
PIPE $3.6M
Undisclosed Investor(s)
May 2010
Exit Undisclosed
Feb 2021
PIPE $35M
Undisclosed Investor(s)
Feb 2020
PIPE $4.45M
Undisclosed Investor(s)
Feb 2012
PIPE $1M
Biomedix, Docor International Management
Feb 2007
Undisclosed Round $2M
Modgal Industries,
Dec 2010
Exit Undisclosed
Apr 2008
Undisclosed Round $8.3M
Docor International Management
Apr 2007
Undisclosed Round $4.5M
Docor International Management
News (138)
Oct 27, 2025 · finance.yahoo.com
growth-positive
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
PartnersCustomers
Oct 20, 2025 · finance.yahoo.com
growth-positive
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
Product Stage
Oct 20, 2025 · www.prnewswire.com
growth-positive
A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D™, outperformed Matrigel®, a leading extracellular matrix,...
Partners
Oct 16, 2025 · finance.yahoo.com
growth-positive
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
Oct 16, 2025 · www.prnewswire.com
growth-positive
The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical research. According to a scientific article published in the...
Partners
Oct 3, 2025 · finance.yahoo.com
growth-positive
One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year
Sep 30, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based...
Product StagePartners
Sep 30, 2025 · finance.yahoo.com
growth-positive
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
Product Stage
Sep 15, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and...
Sep 15, 2025 · finance.yahoo.com
growth-positive
CollPlant Expands the Distribution of its VergenixSTR Product in Europe
Partners
Sep 2, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based...
Partners
Sep 2, 2025 · finance.yahoo.com
growth-positive
CollPlant to Present at the 2025 International Conference on Biofabrication
Aug 25, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based...
Partners
Aug 25, 2025 · www.prnewswire.com
growth-positive
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
Aug 20, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...
Product StageInvestmentPartnersExpand
Aug 20, 2025 · finance.yahoo.com
growth-positive
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
InvestmentPartnersProduct StageExpandManagement Changes
Aug 5, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...
Partners
Aug 5, 2025 · www.prnewswire.com
growth-positive
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS
Partners
Jul 14, 2025 · finance.yahoo.com
growth-positive
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations
Management ChangesExpand
Jul 14, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based...
Management ChangesPartners
+ 118 more articles
Details
Product Stage
Released
Employees
51-200
Exact Count
62
District
Center District
Founded
2004
Registrar
513578260
Crunchbase
collplant
Locations
Prof. Hillel ve-Khanan Oppenheimer St 4, Rehovot, Israel
Yesud HaMa'ala, Israel
Links
Website
collplant.com
LinkedIn
Profile
Twitter
Profile
Facebook
Page
Admin
Last Update
Oct 27, 2025
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
markets
Team (4)
Yehiel Tal
CEO
Eran Rotem
Deputy CEO & CFO
Oded Shoseyov
Founder, Chief Scientist
Founder
Philippe Bensimon
VP Regulatory Affairs and Quality Assurance
Internal
Created by
Rebecca Mack (rebeccamack26@gmail.com)
Created
2014-07-24T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Status
Public on NASDAQ on Dec, 2010;
Finder · CollPlant · 2026